WFG Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-737
| Closed | -$38K | – | 1543 |
|
|
2017
Q1 | $38K | Sell |
737
-13
| -2% | -$670 | 0.01% | 729 |
|
|
2016
Q4 | $28K | Hold |
750
| – | – | 0.01% | 856 |
|
|
2016
Q3 | $51K | Hold |
750
| – | – | 0.01% | 699 |
|
|
2016
Q2 | $42K | Hold |
750
| – | – | 0.01% | 723 |
|
|
2016
Q1 | $47K | Hold |
750
| – | – | 0.01% | 680 |
|
|
2015
Q4 | $71K | Hold |
750
| – | – | 0.02% | 555 |
|
|
2015
Q3 | $60K | Hold |
750
| – | – | 0.02% | 586 |
|
|
2015
Q2 | $90K | Hold |
750
| – | – | 0.02% | 562 |
|
|
2015
Q1 | $78K | Sell |
750
-1,295
| -63% | -$135K | 0.02% | 604 |
|
|
2014
Q4 | $198K | Buy |
2,045
+1,295
| +173% | +$125K | 0.04% | 430 |
|
|
2014
Q3 | $59K | Buy |
750
+291
| +63% | +$22.9K | 0.01% | 861 |
|
|
2014
Q2 | $29K | Buy |
459
+409
| +818% | +$25.8K | 0.01% | 1122 |
|
|
2014
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 1703 |
|
|
2013
Q4 | $3K | Buy |
+50
| New | +$3K | ﹤0.01% | 1855 |
|